Cited by 290Autoimmune and Inflammatory Disorders ResearchImmunodeficiency and Autoimmune DisordersKawasaki Disease and Coronary Complications

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome

Open access

Mazodier, K.·2005·Blood

DOI 10.1182/blood-2005-05-1980PMC PMC1895045

Open this paper in CoChat — free account

Abstract

Hemophagocytic syndrome (HPS) is characterized by an uncontrolled and poorly understood activation of T-helper 1 (Th-1) lymphocytes and macrophages. We studied 20 patients with HPS secondary to infections, autoimmune disease, lymphoma, or cancer and observed that the concentrations of serum interleukin 18 (IL-18), a strong inducer of Th-1 responses, interferon gamma (IFN-gamma) production, and stimulation of macrophages and natural killer (NK) cells were highly increased in HPS but not in control patients. In contrast, concentrations of its natural inhibitor, the IL-18 binding protein (IL-18BP), were only moderately elevated, resulting in a high level of biologically active free IL-18 in HPS (4.6-fold increase compared with controls; P < .001). Free IL-18 but not IL-12 concentrations significantly correlated with clinical status and the biologic markers of HPS such as anemia (P < .001), hypertriglyceridemia, and hyperferritinemia (P < .01) and also with markers of Th-1 lymphocyte or macrophage activation, such as elevated concentrations of IFN-gamma and soluble IL-2 and tumor necrosis factor alpha (TNF-alpha) receptor concentrations. Despite high IL-18 elevation, in vitro NK-cell cytotoxicity was severely impaired in HPS patients, in part due to NK-cell lymphopenia that was observed in a majority of patients but also secondary to an intrinsic NK-cell functional deficiency. We concluded that a severe IL-18/IL-18BP imbalance results in Th-1 lymphocyte and macrophage activation, which escapes control by NK-cell cytotoxicity and may allow for secondary HPS in patients with underlying diseases.

Integrity signals

Registry

Crossref · 10.1182/blood-2005-05-1980

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Interleukin-18 Regulates Both Th1 and Th2 Responses
Nakanishi, K., Yoshimoto, T., Tsutsui, H., & Okamura, H. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.423 · Cited by 1,319
Perforin Gene Defects in Familial Hemophagocytic Lymphohistiocytosis
Stepp, S. E., Dufourcq-Lagelouse, R., Deist, F. L., Bhawan, S., Dogniaux, S., Mathew, P. A., Henter, J., Bennett, M., Fischer, A., Basile, G. D. S., et al. (1999) · Science · doi:10.1126/science.286.5446.1957 · Cited by 1,236
Virus-associated hemophagocytic syndromeA benign histiocytic proliferation distinct from malignant histiocytosis
Risdall, R. J., McKenna, R. W., Nesbit, M. E., Krivit, W. A., Balfour, H. H., Simmons, R. L., & Brunning, R. D. (1979) · Cancer · doi:10.1002/1097-0142(197909)44:3 · Cited by 1,037
Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome
Ménasché, G., Pastural, É., Feldmann, J., Dogniaux, S., Ersoy, F., Dupuis, S., Wulffraat, N. M., Bianchi, D. W., Fischer, A., Deist, F. L., et al. (2000) · Nature Genetics · doi:10.1038/76024 · Cited by 957
IL-18: A TH1 -inducing, proinflammatory cytokine and new member of the IL-1 family
Dinarello, C. A. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70518-x · Cited by 817
Interleukin-18 Binding Protein
Novick, D., Kim, S. H., Fantuzzi, G., Reznikov, L. L., Dinarello, C. A., & Rubinstein, M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80013-8 · Cited by 781
Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society.
Henter, J., Elinder, G., & Öst, Å. (1991) · PubMed · Cited by 762
An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder
Jordan, M. B., Hildeman, D., Kappler, J., & Marrack, P. (2004) · Blood · doi:10.1182/blood-2003-10-3413 · Cited by 712
A proinflammatory role for IL-18 in rheumatoid arthritis
Gracie, J. A., Forsey, R. J., Chan, W. L., Gilmour, A., Leung, B. P. L., Greer, M. R., Kennedy, K., Carter, R., Wei, X., Xu, D., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7317 · Cited by 635
IL-18, a Novel Immunoregulatory Cytokine, Is Up-Regulated in Crohn’s Disease: Expression and Localization in Intestinal Mucosal Cells
Pizarro, T. T., Michie, M. H., Bentz, M., Woraratanadharm, J., Smith, M. F., Foley, E. F., Moskaluk, C. A., Bickston, S. J., & Cominelli, F. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6829 · Cited by 573

Show all 47 references

Sorted by citations

Immunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466
Cytokine storm
Fajgenbaum, D. C., & June, C. H. (2020) · New England Journal of Medicine · doi:10.1056/nejmra2026131 · Cited by 3,196
Overview of the IL ‐1 family in innate inflammation and acquired immunity
Dinarello, C. A. (2018) · Immunological Reviews · doi:10.1111/imr.12621 · Cited by 1,866
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
Dinarello, C. A., Simon, A., & van der Meer, J. W. M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3800 · Cited by 1,812
Adult haemophagocytic syndrome
Ramos‐Casals, M., Brito‐Zerón, P., López‐Guillermo, A., Khamashta, M. A., & Bosch, X. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61048-x · Cited by 1,445
Interleukin-18 and IL-18 Binding Protein
Dinarello, C. A., Novick, D., Kim, S., & Kaplanski, G. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00289 · Cited by 938
IL‐1, IL‐18, and IL‐33 families of cytokines
Arend, W. P., Palmer, G., & Gabay, C. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00624.x · Cited by 937
Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial*
Shakoory, B., Carcillo, J. A., Chatham, W. W., Amdur, R. L., Zhao, H., Dinarello, C. A., Cron, R. Q., & Opal, S. M. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001402 · Cited by 867
A clinical perspective of IL‐1β as the gatekeeper of inflammation
Dinarello, C. A. (2011) · European Journal of Immunology · doi:10.1002/eji.201141550 · Cited by 792
An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome
Canna, S., de Jesus, A. A., Gouni, S., Brooks, S. R., Marrero, B., Liu, Y., DiMattia, M. A., Zaal, K. J. M., Sanchez, G. A. M., Kim, H., et al. (2014) · Nature Genetics · doi:10.1038/ng.3089 · Cited by 747
Interleukin‐18: Biological properties and role in disease pathogenesis
Kaplanski, G. (2017) · Immunological Reviews · doi:10.1111/imr.12616 · Cited by 621
OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation
Marchetti, C., Swartzwelter, B. J., Gamboni, F., Neff, C. P., Richter, K., Azam, T., Carta, S., Tengesdal, I. W., Nemkov, T. G., D’Alessandro, A., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1716095115 · Cited by 605
Interleukin-18 in Health and Disease
Yasuda, K., Nakanishi, K., & Tsutsui, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030649 · Cited by 583
Immunopathogenesis and treatment of cytokine storm in COVID-19
Kim, J., Lee, J. Y., Yang, J. W., Lee, K. H., Effenberger, M., Szpirt, W. M., Kronbichler, A., & Shin, J. I. (2020) · Theranostics · doi:10.7150/thno.49713 · Cited by 477
Macrophage activation syndrome in the era of biologic therapy
Grom, A. A., Horne, A., & Benedetti, F. D. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.179 · Cited by 450
The ‘cytokine storm’: molecular mechanisms and therapeutic prospects
Karki, R., & Kanneganti, T. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.06.001 · Cited by 464
Juvenile Idiopathic Arthritis
Benedetti, F. D., & Ravelli, A. (2000) · BioDrugs · doi:10.2165/00063030-200014020-00003 · Cited by 430
Pathogenesis of Macrophage Activation Syndrome and Potential for Cytokine- Directed Therapies
Schulert, G. S., & Grom, A. A. (2014) · Annual Review of Medicine · doi:10.1146/annurev-med-061813-012806 · Cited by 401
Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome
Weiss, E. S., Girard-Guyonvarc’h, C., Holzinger, D., de Jesus, A. A., Tariq, Z., Picarsic, J. L., Schiffrin, E. J., Foell, D., Grom, A. A., Ammann, S., et al. (2018) · Blood · doi:10.1182/blood-2017-12-820852 · Cited by 406
IL-18 Induces PD-1–Dependent Immunosuppression in Cancer
Terme, M., Ullrich, E., Aymeric, L., Meinhardt, K., Desbois, M., Delahaye, N., Viaud, S., Ryffel, B., Yagita, H., Kaplanski, G., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0993 · Cited by 376
The IL-1 family of cytokines and receptors in rheumatic diseases
Dinarello, C. A. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0277-8 · Cited by 387
Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: A systematic scoping review
Hayden, A. R., Park, S., Giustini, D., Lee, A. Y. Y., & Chen, L. Y. C. (2016) · Blood Reviews · doi:10.1016/j.blre.2016.05.001 · Cited by 339
Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions
Mellins, E., Macaubas, C., & Grom, A. A. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.68 · Cited by 337
Inflammasome-independent regulation of IL-1-family cytokines
Netea, M. G., van de Veerdonk, F. L., van der Meer, J. W. M., Dinarello, C. A., & Joosten, L. A. B. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112306 · Cited by 326
IL-1β/IL-6/CRP and IL-18/ferritin: Distinct Inflammatory Programs in Infections
Slaats, J., ten Oever, J., van de Veerdonk, F. L., & Netea, M. G. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005973 · Cited by 331
Review: Cytokine Storm Syndrome: Looking Toward the Precision Medicine Era
Behrens, E. M., & Koretzky, G. A. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40071 · Cited by 307
Anakinra Therapy for Non-cancer Inflammatory Diseases
Cavalli, G., & Dinarello, C. A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01157 · Cited by 307
Suppression of inflammation and acquired immunity by IL ‐37
Cavalli, G., & Dinarello, C. A. (2017) · Immunological Reviews · doi:10.1111/imr.12605 · Cited by 291
Natural killer cell–directed therapies: moving from unexpected results to successful strategies
Terme, M., Ullrich, E., Delahaye, N. F., Chaput, N., & Zitvogel, L. (2008) · Nature Immunology · doi:10.1038/ni1580 · Cited by 302
Interleukin-18, more than a Th1 cytokine
Novick, D., Kim, S., Kaplanski, G., & Dinarello, C. A. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.014 · Cited by 280
IL‐1: Discoveries, controversies and future directions
Dinarello, C. A. (2010) · European Journal of Immunology · doi:10.1002/eji.201040319 · Cited by 275
Interleukin-18 and the Pathogenesis of Inflammatory Diseases
Dinarello, C. A. (2007) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2006.09.013 · Cited by 249
Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases
de Jesus, A. A., Hou, Y., Brooks, S. R., Malle, L., Biancotto, A., Huang, Y., Calvo, K. R., Marrero, B., Moir, S. L., Oler, A. J., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129301 · Cited by 241
Divergence of IL-1, IL-18, and cell death in NLRP3 inflammasomopathies
Brydges, S. D., Broderick, L., McGeough, M. D., Peña, C. A., Mueller, J. L., & Hoffman, H. M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci71543 · Cited by 234
Macrophage Activation Syndrome
Ravelli, A., Davì, S., Minoia, F., Martini, A., & Cron, R. Q. (2015) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2015.06.010 · Cited by 211
Macrophage activation-like syndrome: an immunological entity associated with rapid progression to death in sepsis
on behalf of the Hellenic Sepsis Study Group, Kyriazopoulou, E., Leventogiannis, K., Norrby‐Teglund, A., Dimopoulos, G., Pantazi, A., Orfanos, S. E., Rovina, N., Tsangaris, I., Gkavogianni, T., et al. (2017) · BMC Medicine · doi:10.1186/s12916-017-0930-5 · Cited by 212
Hemophagocytic lymphohistiocytosis (HLH): A heterogeneous spectrum of cytokine-driven immune disorders
Brisse, E., Wouters, C. H., & Matthys, P. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.10.001 · Cited by 206
Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells
Lichtenstein, D. A., Schischlik, F., Shao, L., Steinberg, S. M., Yates, B., Wang, H., Wang, Y., Inglefield, J. R., Dulau-Florea, A., Ceppi, F., et al. (2021) · Blood · doi:10.1182/blood.2021011898 · Cited by 198
Neutralization of IFNγ defeats haemophagocytosis in LCMV‐infected perforin‐ and Rab27a‐deficient mice
Schmid, J. P., Ho, C. H., Chrétien, F. C., Lefebvre, J. M., Pivert, G., Kosco‐Vilbois, M. H., Ferlin, W. G., Geissmann, F., Fischer, A., & Basile, G. D. S. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900009 · Cited by 196
Therapeutic effect of JAK1/2 blockade on the manifestations of hemophagocytic lymphohistiocytosis in mice
Maschalidi, S., Sepulveda, F. E., Garrigue, A., Fischer, A., & Basile, G. D. S. (2016) · Blood · doi:10.1182/blood-2016-02-700013 · Cited by 196
Drug-Induced Hypersensitivity Syndrome
m’rad, M. B., Leclerc‐Mercier, S., Blanche, P., Franck, N., Rozenberg, F., Fulla, Y., Guesmi, M., Rollot, F., Dehoux, M., Guillevin, L., et al. (2009) · Medicine · doi:10.1097/md.0b013e3181a4d1a1 · Cited by 194
Early diagnostic and prognostic significance of a specific Th1/Th2 cytokine pattern in children with haemophagocytic syndrome
Tang, Y., Xu, X., Song, H., Yang, S., Shi, S., Wei, J., Pan, B., Zhao, F., Liao, C., & Luo, C. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07298.x · Cited by 186
Pathogenesis of adult-onset Still’s disease: new insights from the juvenile counterpart
Jamilloux, Y., Gerfaud‐Valentin, M., Martinon, F., Bélot, A., Henry, T., & Sève, P. (2014) · Immunologic Research · doi:10.1007/s12026-014-8561-9 · Cited by 188
Tuberculosis-associated haemophagocytic syndrome
Brastianos, P. K., Swanson, J. W., Torbenson, M. S., Sperati, C. J., & Karakousis, P. C. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70524-2 · Cited by 183
Inherited defects in lymphocyte cytotoxic activity
Schmid, J. P., Côte, M., Ménager, M. M., Burgess, A., Nehme, N. T., Ménasché, G., Fischer, A., & Basile, G. D. S. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2010.00890.x · Cited by 178
Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis
Gono, T., Kawaguchi, Y., Hara, M., Masuda, I., Katsumata, Y., Shinozaki, M., Ota, Y., Ozeki, E., & Yamanaka, H. (2010) · Lara D. Veeken · doi:10.1093/rheumatology/keq073 · Cited by 171
Elevated serum levels of free interleukin-18 in adult-onset Still’s disease
Girard, C., Rech, J., Brown, M., Allali, D., Roux‐Lombard, P., Spertini, F., Schiffrin, E. J., Schett, G. A., Manger, B., Bas, S., et al. (2016) · Lara D. Veeken · doi:10.1093/rheumatology/kew300 · Cited by 166
Gamma-delta T-cell lymphomas
Tripodo, C., D, E. I. M., Florena, A. M., Pucillo, C. E. M., Piccaluga, P. P., Franco, V., & Pileri, S. A. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.169 · Cited by 164
Macrophage activation syndrome and cytokine-directed therapies
Schulert, G. S., & Grom, A. A. (2014) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2014.03.002 · Cited by 163
Natural killer cells in human autoimmune diseases
SCHLEINITZ, N., Vely, F., Harlé, J., & Vivier, É. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03360.x · Cited by 158
Haemophagocytic syndrome in rheumatic patients. A systematic review.
Atteritano, M., David, A., Bagnato, G., Beninati, C., Frisina, A., Iaria, C., Bagnato, G., & Cascio, A. (2012) · PubMed · Cited by 157
A novel Pyrin-Associated Autoinflammation with Neutrophilic Dermatosis mutation further defines 14-3-3 binding of pyrin and distinction to Familial Mediterranean Fever
Moghaddas, F., Llamas, R., Nardo, D. D., Martínez‐Banaclocha, H., Martínez-García, J. J., Mesa-del-Castillo, P., Baker, P. J., Gargallo, V., Mensa‐Vilaró, A., Canna, S., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-211473 · Cited by 158
Life-threatening complications of adult-onset Still’s disease
Efthimiou, P., Kadavath, S. M., & Mehta, B. Y. (2014) · Clinical Rheumatology · doi:10.1007/s10067-014-2487-4 · Cited by 148
Clinical utility of soluble interleukin-2 receptor in hemophagocytic syndromes: a systematic scoping review
Lin, M., Park, S., Hayden, A. R., Giustini, D., Trinkaus, M. A., Pudek, M. R., Mattman, A., Schneider, M., & Chen, L. Y. C. (2017) · Annals of Hematology · doi:10.1007/s00277-017-2993-y · Cited by 150
Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ
Put, K., Avau, A., Brisse, E., Mitera, T., Put, S., Proost, P., Bader‐Meunier, B., Westhovens, R., den Eynde, B. J. V., Orabona, C., et al. (2015) · Rheumatology · doi:10.1093/rheumatology/keu524 · Cited by 148
Unopposed IL-18 signaling leads to severe TLR9-induced macrophage activation syndrome in mice
Girard-Guyonvarc’h, C., Palomo, J., Martin, P., Rodriguez, E., Troccaz, S., Palmer, G., & Gabay, C. (2018) · Blood · doi:10.1182/blood-2017-06-789552 · Cited by 139
NCR3/NKp30 Contributes to Pathogenesis in Primary Sjögren’s Syndrome
Rusakiewicz, S., Nocturne, G., Lazure, T., Semeraro, M., Flament, C., Caillat‐Zucman, S., Sène, D., Delahaye, N., Vivier, É., Chaba, K., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005727 · Cited by 129
Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab
Grom, A. A., Ilowite, N. T., Pascual, V., Brunner, H. I., Martini, A., Lovell, D. J., Ruperto, N., Leon, K., Lheritier, K., & Abrams, K. B. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39407 · Cited by 129
Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles
Shimizu, M., Nakagishi, Y., & Yachie, A. (2013) · Cytokine · doi:10.1016/j.cyto.2012.11.025 · Cited by 128
IL‐18 and infections: Is there a role for targeted therapies?
Vecchié, A., Bonaventura, A., Toldo, S. A., Dagna, L., Dinarello, C. A., & Abbate, A. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30008 · Cited by 127
Interleukin-18 in Inflammatory Kidney Disease
Hirooka, Y., & Nozaki, Y. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.639103 · Cited by 135
Clinical and experimental approaches to the pathophysiology of interleukin-18 in cancer progression
Vidal‐Vanaclocha, F., Mendoza, L., Tellería, N., Salado, C., Valcárcel, M., Gallot, N., Carrascal, T., Egilegor, E., Beaskoetxea, J., & Dinarello, C. A. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9013-3 · Cited by 122
Cancer-Induced Immunosuppression: IL-18–Elicited Immunoablative NK Cells
Terme, M., Ullrich, E., Aymeric, L., Meinhardt, K., Coudert, J. D., Desbois, M., Ghiringhelli, F., Viaud, S., Ryffel, B., Yagita∥, H., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3379 · Cited by 117
Reactive haemophagocytic syndrome in 58 HIV-1-infected patients: clinical features, underlying diseases and prognosis
Fardet, L., Lambotte, O., Meynard, J., Kamouh, W., Galicier, L., Marzac, C., de Labarthe, A., Cabané, J., Lebbé, C., Coppo, P., et al. (2010) · AIDS · doi:10.1097/qad.0b013e328339e55b · Cited by 115
Inflammatory Mediators of Endothelial Dysfunction
Dri, E., Lampas, E., Lazaros, G. A., Lazarou, E., Theofilis, P., Tsioufis, C. P., & Tousoulis, D. (2023) · Life · doi:10.3390/life13061420 · Cited by 132
IL-18 as a biomarker linking systemic juvenile idiopathic arthritis and macrophage activation syndrome
Yasin, S., Fall, N., Brown, R. A., Henderlight, M., Canna, S., Girard-Guyonvarc’h, C., Gabay, C., Grom, A. A., & Schulert, G. S. (2019) · Lara D. Veeken · doi:10.1093/rheumatology/kez282 · Cited by 114
Interleukin-18, the Metabolic Syndrome, and Subclinical Atherosclerosis
Zirlik, A., Abdullah, S. M., Gerdes, N., MacFarlane, L. A., Schönbeck, U., Khera, A., McGuire, D. K., Vega, G. L., Grundy, S. M., Libby, P., et al. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.149484 · Cited by 113
Hemophagocytic lymphohistiocytosis: current treatment advances, emerging targeted therapy and underlying mechanisms
Wu, Y., Sun, X., Kang, K., Yang, Y., Li, H., Zhao, A., & Niu, T. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01621-x · Cited by 115
Understanding the spectrum of haemophagocytic lymphohistiocytosis: update on diagnostic challenges and therapeutic options
Brisse, E., Matthys, P., & Wouters, C. H. (2016) · British Journal of Haematology · doi:10.1111/bjh.14144 · Cited by 102
IL-18 binding protein-expressing mesenchymal stem cells improve myocardial protection after ischemia or infarction
Wang, M., Tan, J., Wang, Y., Meldrum, K. K., Dinarello, C. A., & Meldrum, D. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908924106 · Cited by 98
The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all?
Morris, G., Bortolasci, C. C., Puri, B. K., Marx, W., O'Neil, A. E., Athan, E., Walder, K. R., Berk, M., OLIVE, L. S., Carvalho, A. F., et al. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155593 · Cited by 101
High circulating levels of free interleukin-18 in patients with active SLE in the presence of elevated levels of interleukin-18 binding protein
Novick, D., Elbirt, D., Miller, G., Dinarello, C. A., Rubinstein, M., & Sthoeger, Z. M. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.08.002 · Cited by 95
Functional and genetic testing in adults with HLH reveals an inflammatory profile rather than a cytotoxicity defect
Carvelli, J., Pipéroglou, C., Farnarier, C., Vely, F., Mazodier, K., Audonnet, S., Nitschké, P., Bôle‐Feysot, C., Boucékine, M., Cambon, A., et al. (2020) · Blood · doi:10.1182/blood.2019003664 · Cited by 94
Self-citation
The Role of Natural Killer Cells in Sepsis
Chiche, L., Forel, J.-M., Thomas, G., Farnarier, C., Vely, F., Bléry, M., Papazian, L., & Vivier, É. (2011) · BioMed Research International · doi:10.1155/2011/986491 · Cited by 92
Reaching the Threshold: A Multilayer Pathogenesis of Macrophage Activation Syndrome
Strippoli, R., Caiello, I., & Benedetti, F. D. (2013) · The Journal of Rheumatology · doi:10.3899/jrheum.121233 · Cited by 85
First report of macrophage activation syndrome in hyperimmunoglobulinemia D with periodic fever syndrome
Rigante, D., Capoluongo, E., Bertoni, B., Ansuini, V., Chiaretti, A., Piastra, M., Pulitanò, S., Genovese, O., Compagnone, A., & Stabile, A. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22409 · Cited by 78
Mediators of Innate and Adaptive Immune Responses Differentially Affect Immune Restoration Disease Associated withMycobacterium tuberculosisin HIV Patients Beginning Antiretroviral Therapy
Oliver, B. G., Elliott, J., Price, P., Phillips, M. R., Saphonn, V., Vun, M. C., Kaldor, J. M., Cooper, D. A., & French, M. A. (2010) · The Journal of Infectious Diseases · doi:10.1086/657082 · Cited by 79
Crimean‐Congo hemorrhagic fever: Five patients with hemophagocytic syndrome
Fışgın, N. T., Fışgın, T., Tanyel, E., Doğancı, L., Tülek, N., Güler, N., & Duru, F. (2007) · American Journal of Hematology · doi:10.1002/ajh.20969 · Cited by 76
Diagnostic and management of life-threatening Adult-Onset Still Disease: a French nationwide multicenter study and systematic literature review
Néel, A., Wahbi, A., Tessoulin, B., Boileau, J., Carpentier, D., Decaux, O., Fardet, L., Géri, G., Godmer, P., Goujard, C., et al. (2018) · Critical Care · doi:10.1186/s13054-018-2012-2 · Cited by 76
Protection from Inflammatory Organ Damage in a Murine Model of Hemophagocytic Lymphohistiocytosis Using Treatment with IL-18 Binding Protein
Chiossone, L., Audonnet, S., Chetaille, B., Chasson, L., Farnarier, C., Berda‐Haddad, Y., Jordan, S., Koszinowski, U. H., Dalod, M., Mazodier, K., et al. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00239 · Cited by 75
Self-citation
Macrophage activation syndrome in the course of monogenic autoinflammatory disorders
Rigante, D., Emmi, G., Fastiggi, M., Silvestri, E., & Cantarini, L. (2015) · Clinical Rheumatology · doi:10.1007/s10067-015-2923-0 · Cited by 73
Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age
Poynard, T., Munteanu, M., Deckmyn, O., Ngo, Y., Drane, F., Messous, D., Castille, J. M., Housset, C., Ratziu, V., & Imbert‐Bismut, F. (2011) · BMC Gastroenterology · doi:10.1186/1471-230x-11-39 · Cited by 73
From bench to bedside and back again: translational research in autoinflammation
Holzinger, D., Kessel, C., Omenetti, A., & Gattorno, M. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.79 · Cited by 69
Interleukin-18/WNT1-inducible signaling pathway protein-1 signaling mediates human saphenous vein smooth muscle cell proliferation
Reddy, V. S., Valente, A. J., Delafontaine, P., & Chandrasekar, B. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22676 · Cited by 68
A Griscelli syndrome type 2 murine model of hemophagocytic lymphohistiocytosis (HLH)
Schmid, J. P., Ho, C., Diana, J., Pivert, G., Lehuen, A., Geissmann, F., Fischer, A., & Basile, G. D. S. (2008) · European Journal of Immunology · doi:10.1002/eji.200838488 · Cited by 67
An IL-18-centered inflammatory network as a biomarker for cerebral white matter injury
Altendahl, M., Maillard, P., Harvey, D. J., Cotter, D. L., Walters, S. M., Wolf, A. A., Singh, B., Kakarla, V., Azizkhanian, I., Sheth, S. A., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227835 · Cited by 66
The microenvironment in T-cell lymphomas: Emerging themes
Gaulard, P., & de Leval, L. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.11.004 · Cited by 65
Interleukin-18 is a key mediator in dermatomyositis: potential contribution to development of interstitial lung disease
Gono, T., Kawaguchi, Y., Sugiura, T., Ichida, H., Takagi, K., Katsumata, Y., Hanaoka, M., Okamoto, Y., Ota, Y., & Yamanaka, H. (2010) · Lara D. Veeken · doi:10.1093/rheumatology/keq196 · Cited by 63
Mutations in cryopyrin: Bypassing roadblocks in the caspase 1 inflammasome for interleukin‐1β secretion and disease activity
Dinarello, C. A. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22841 · Cited by 61
The role of interleukin-18 in the diagnosis and monitoring of hemophagocytic lymphohistiocytosis/macrophage activation syndrome – a systematic review
Krei, J. M., Møller, H. J., & Larsen, J. B. (2020) · Clinical & Experimental Immunology · doi:10.1111/cei.13543 · Cited by 64
Local and systemic interleukin-18 and interleukin-18-binding protein in children with inflammatory bowel disease
Leach, S. T., Messina, I., Lemberg, D. A., Novick, D., Rubenstein, M., & Day, A. S. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20272 · Cited by 59
The unique aspects of presentation and diagnosis of hemophagocytic lymphohistiocytosis in adults
Nikiforow, S., & Berliner, N. (2015) · Hematology · doi:10.1182/asheducation-2015.1.183 · Cited by 58
IL-18 Serum Concentration Is Markedly Elevated in Acute EBV Infection and Can Serve as a Marker for Disease Severity
van de Veerdonk, F. L., Wever, P. C., Hermans, M. H. A., Fijnheer, R., Joosten, L. A. B., van der Meer, J. W. M., Netea, M. G., & Schneeberger, P. M. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis335 · Cited by 56
Interleukin-18 and IL-18BP in inflammatory dermatological diseases
Wang, X., Wang, L., Wen, X., Zhang, L., Jiang, X. L., & He, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.955369 · Cited by 54
Haemophagocytic syndrome--a life-threatening complication of renal transplantation
Ponticelli, C. E., & Alberighi, O. D. C. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp282 · Cited by 54
IP-10/CXCL10 and MIG/CXCL9 as novel markers for the diagnosis of lymphoma-associated hemophagocytic syndrome
Maruoka, H., Inoue, D., Takiuchi, Y., Nagano, S., Arima, H., Tabata, S., Matsushita, A., Ishikawa, T., Oita, T., & Takahashi, T. (2013) · Annals of Hematology · doi:10.1007/s00277-013-1878-y · Cited by 53
IL-18 and IL-18BP: A Unique Dyad in Health and Disease
Novick, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413505 · Cited by 56
Comparative study of four fluorescent probes for evaluation of natural killer cell cytotoxicity assays
Cholujová, D., Jakubı́ková, J., Kubeš, M., Arendacká, B., Sapák, M., Ihnatko, R., & Sedlák, J. (2008) · Immunobiology · doi:10.1016/j.imbio.2008.02.006 · Cited by 52
Old Dogs, New Tricks: Monogenic Autoinflammatory Disease Unleashed
Stoffels, M., & Kastner, D. L. (2016) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090413-025334 · Cited by 53
IL-18/IL-18BP and IL-22/IL-22BP: Two interrelated couples with therapeutic potential
Mühl, H., & Bachmann, M. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.109388 · Cited by 51

Authors: Mazodier, K.
Affiliations: Inserm (FR)
Corresponding author: Mazodier, K.
Venue: Blood
Publisher: American Society of Hematology
Published: 2005-11-15
Volume: 106
Issue: 10
Pages: 3483-3489
ISSN: 0006-4971 (ISSN-L)
1528-0020
DOI: 10.1182/blood-2005-05-1980
PMC: PMC1895045
OpenAlex: W2157675757
Cited by: 290
References: 47
Citations by year: 2026: 7 · 2025: 6 · 2024: 19 · 2023: 16 · 2022: 16 · 2021: 17 · 2020: 13 · 2019: 19 · 2018: 19 · 2017: 18 · 2016: 14 · 2015: 13 · 2014: 17 · 2013: 13 · 2012: 12
FWCI: 5.34
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Blood (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Heart, Lung, and Blood Institute (HL68743, P01HL068743)
National Institute of Allergy and Infectious Diseases (AI‑15614)
Topics: Health Sciences › Medicine › Hematology › Autoimmune and Inflammatory Disorders Research
Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Kawasaki Disease and Coronary Complications
Keywords: hemophagocytic lymphohistiocytosis, secondary hemophagocytic lymphohistiocytosis, IL-18, IL-18BP, macrophage activation, interferon-gamma, NK cell cytotoxicity, hyperferritinemia, hypertriglyceridemia, anemia, soluble interleukin-2 receptor, TNF-alpha receptor, cytokine imbalance
MeSH terms: Adolescent, Adult, Aged, Aged, 80 and over, Autoimmune Diseases, Female, Glycoproteins, Humans, Leukocytes, Lymphocyte Activation, Lymphopenia, Macrophage Activation, Male, Middle Aged, Neoplasms, Prospective Studies, Biomarkers, Cytokines, Interleukin-18, Intercellular Signaling Peptides and Proteins, Lymphohistiocytosis, Hemophagocytic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks